Direct cost of hemodialysis in a public hospital in the Dominican Republic

Jiménez-Ramírez R, Martínez-Paulino A, De Jesús-De la Cruz E, López-González FE. Direct cost of hemodialysis in a public hospital in the Dominican Republic. Rev. Colomb. Nefrol. [Internet]. 2023 Dec. 18 [cited 2024 Apr. 27];10(3). Available from: https://revistanefrologia.org/index.php/rcn/article/view/712

Abstract

Introduction: Hemodialysis represents a high expense for patients with end-stage renal disease, the family budget, and the per capita health expenditure of the Dominican Republic government.

Objective: To estimate the direct costs of hemodialysis among patients with end-stage renal

disease (ESRD) at Salvador B. Gautier Hospital.

Methodology: A descriptive cross-sectional study was conducted among 59 ESRD patients undergoing hemodialysis therapy in a tertiary public hospital in the Dominican Republic from

July 26th to August 23rd, 2021. Data were collected through interviews with the participants and a review of clinical records. A total of 718 hemodialysis sessions were studied and direct costs were estimated using the bottom-up method.

Results: The mean cost per hemodialysis session was DOP 4,880.51 (USD 85.91) and the mean annual cost was DOP 761,359.56 (USD 13,401.86). Direct medical costs represented 50.06% and direct non-medical costs 49.94%. Medical supplies and transportation represented 40.86% and 24.79% of total costs, respectively.

Conclusions: Hemodialysis imposes a considerable economic burden for the Dominican Republic. The income of the families is not sufficient to cover hemodialysis treatment. To reduce the economic impact of hemodialysis, strategies should be implemented to prevent the progression of chronic kidney disease to the end stage.

https://doi.org/10.22265/acnef.10.3.712

PDF

xml (Español)

References

Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and

national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020;395(10225):709-33. https://doi.org/10.1016/S0140-6736(20)30045-3

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to

treatment for end-stage kidney disease: a systematic review. The Lancet. 2015;385(9981):1975-1982. https://doi.org/10.1016/S0140-6736(14)61601-9

United States Renal Data System. USRDS 2021 Annual Data Report: Epidemiology of kidney disease in the United States [Internet]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2021 [cited 2022 Apr 10]. Available from: https://doi.org/10.1053/j.ajkd.2022.02.001

Global Facts: About Kidney Disease [Internet]. National Kidney Foundation. 2015 [cited June 12, 2023]. Available at: https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease

Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B. Estimating the financial cost of

chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(suppl 3):73-80. https://doi.org/10.1093/ndt/gfs269

Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease

to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-1270. https://doi.org/10.1038/ki.2011.368

Chapko MK, Liu CF, Perkins M, Li YF, Fortney JC, Maciejewski ML. Equivalence of two

healthcare costing methods: bottom-up and top-down. Health Econ. 2009;18(10):1188–201. https://doi.org/10.1002/hec.1422

Hidalgo N. Estimación de la Canasta Básica y las Líneas de Pobreza [Internet]. Oficina Nacional de Estadística; 2012 [cited 2022 Apr 5]. Available from: https://www.one.gob.do/media/tbgk5qqk/documento-canasta-b%C3%A1sica-lineas-pobreza.pdf

Banco Central de la República Dominicana. Histórico de tasa de cambio del dólar [Internet]. [cited 2022 Apr 10]. Available from: https://www.bancentral.gov.do/SectorExterno/HistoricoTasas

Servicio Nacional de Salud. Los riñones son órganos vitales ¡cuídalos! [Internet]. SNS Digital. 2021 [cited 2022 Apr 14]. Available from: https://snsdigital.gob.do/los-rinones-son-organos-vitales-cuidalos/

Villarreal-Ríos E, Palacios-Mateos AF, Galicia-Rodríguez L, Vargas-Daza ER, Baca-Moreno C, Lugo-Rodríguez A. Costo institucional del paciente con enfermedad renal crónica manejada con hemodiálisis. Rev Med Inst Mex Seguro Soc. 2020;58(6):698-708.

Kassa DA, Mekonnen S, Kebede A, Haile TG. Cost of Hemodialysis Treatment and Associated Factors Among End-Stage Renal Disease Patients at the Tertiary Hospitals of Addis Ababa City and Amhara Region, Ethiopia. Clin Outcomes Res CEOR. 2020;12:399–409. http://doi.org/10.2147/CEOR.S256947

Fathima S, Mateti U, Philip M, Kamath J. Pharmacoeconomic evaluation of hemodialysis

patients: A study of cost of illness. J Integr Nephrol Androl. 2018;5(2):54. http://doi.org/10.4103/jina.jina_4_18

Suja A, Anju R, Anju V, Neethu J, Peeyush P, Saraswathy R. Economic evaluation of end

stage renal disease patients undergoing hemodialysis. J Pharm Bioallied Sci. 2012;4(2):107–11. https://doi.org/10.4103/0975-7406.94810

Ranasinghe P, Perera YS, Makarim MF, Wijesinghe A, Wanigasuriya K. The costs in provision of hemodialysis in a developing country: A multi-centered study. BMC Nephrol. 2011;12(1):42. https://doi.org/10.1186/1471-2369-12-42

Elsharif ME, Elsharif EG, Gadour WH. Costs of hemodialysis and kidney transplantation in Sudan: a single center experience. Iran J Kidney Dis. 2010;4(4):282–4. https://pubmed.ncbi.nlm.nih.gov/20852367/

Mahdavi-Mazdeh M, Zamani M, Zamyadi M, Rajolani H, Tajbakhsh K, Heidary Rouchi A, et al. Hemodialysis cost in Tehran, Iran. Hemodial Int. 2008;12(4):492–8. https://doi.org/10.1111/j.1542-4758.2008.00313.x

Kaur G, Prinja S, Ramachandran R, Malhotra P, Gupta KL, Jha V. Cost of hemodialysis in

a public sector tertiary hospital of India. Clin Kidney J. 2018;11(5):726–33. https://doi.org/10.1093/ckj/sfx152

Aoun M, Helou E, Sleilaty G, Zeenny RM, Chelala D. Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives. BMC Health Serv Res. 2022;22(1):586. https://doi.org/10.1186/s12913-022-07936-0

Sánchez-Escuredo A, Alsina A, Diekmann F, Revuelta I, Esforzado N, Ricart MJ, et al. Economic Analysis of the Treatment of End-stage Renal Disease Treatment: Living-donor Kidney Transplantation Versus Hemodialysis. Transplant Proc. 2015;47(1):30–3. https://doi.org/10.1016/j.transproceed.2014.12.005

Mendes de Abreu M, Walker DR, Sesso RC, Ferraz MB. A Cost Evaluation of Peritoneal Dialysis and Hemodialysis in the Treatment of End-Stage Renal Disease in São Paulo, Brazil. Perit Dial Int J. 2013;33(3):304–15. https://doi.org/10.3747/pdi.2011.00138

Saran KA, Sabry A. The cost of hemodialysis in a large hemodialysis center. Saudi J Kidney Dis Transplant. 2012;23(1):78. http://dx.doi.org/10.4103/1319-2442.91306

Pacheco A, Saffie A, Torres R, Tortella C, Llanos C, Vargas D, et al. Cost/Utility study of

peritoneal dialysis and hemodialysis in Chile. Perit Dial Int. 2007;27(3):359–63. https://doi.org/10.1177/089686080702700328

Banco Central de la República Dominicana. Precios [Internet]. [cited 2022 Apr 12]. Available from: https://www.bancentral.gov.do/a/d/2534-precios

Banco Central de la República Dominicana. Sector real [Internet]. [cited 2022 Apr 10]. Available from: https://www.bancentral.gov.do/a/d/2533-sector-real

Texas Health and Human Services. Cost Effective and Clinically Appropriate Methods to Deliver Dialysis Services in the Medicaid Program. 1st. ed. Texas: Texas Health and Human Services; 2022.